Stock NOVABAY PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. NovaBay Pharmaceuticals, Inc. Nyse

Equities

US66987P1021

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for NovaBay Pharmaceuticals, Inc.
05-09 NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-09 Earnings Flash (NBY) NOVABAY PHARMACEUTICALS Reports Q1 Revenue $2.63M, vs. Street Est of $3.28M MT

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ladenburg Thalmann Cuts Price Target on NovaBay Pharmaceuticals to $3.80 From $6, Maintains Buy Rating
MT
NOVABAY PHARMACEUTICALS : Ladenburg Thalmann Adjusts NovaBay Pharmaceuticals PT to $2.20 From $1.90, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Stock
  5. News NovaBay Pharmaceuticals, Inc.
  6. Analyst Reco.